[ad_1]
July 28, 2018
While blood and bone marrow transplants can save the life of a patient with pediatric cancer, a research from the University of Alabama in Birmingham showed that these patients are at increased risk of premature death. decades after the procedure compared to the general population.
Smita Bhatia, MD, MPH, Professor of Pediatric Oncology at UAB and Director of the Institute for Cancer and Survival at the UAB School of Medicine, was the Primary author of results of an observational study in the Journal of the American Medical Association Oncology. The study badyzed data on the cause of death of nearly 1,400 patients who lived two years or more after having undergone an allogeneic blood or bone marrow transplant between 1974 and 2010.
Leading causes of death in the cohort were infection and chronic graft versus host disease, primary disease of patients and subsequent cancers. The data also indicated that the subsequent death rate in these transplant patients has decreased over the last three decades. The authors say that it is promising to know that mortality rates have dropped, and the research gives more insight into the causes of late mortality in this population, and how to help other patients go from there. Before
"are able to save the life of the child during their cancer treatment, we must continue to provide proactive follow-up care to these types of patients throughout their lives, as they are still a population at risk, "said Bhatia. . "The high intensity of therapeutic exposures at a young age lends itself to causing morbidities and compromises in organs once they reach adulthood."
Source:
http://www.uab.edu/news/research/item/ 9631-uab-researcher-finds-the-risk-of-late-death-after-donor- of marrow-of-blood-transplantation in childhood
[ad_2]
Source link
